top of page
Blue Modern Medical Center Flyer (2)_edited.jpg

MFAT LIPOASPIRATE "STEM CELLS"

STEM CELL Therapy Injections in Raleigh & Cary, NC 

WHAT IS MFAT LIPOASPIRATE THERAPY (Stem Cells)?

Carolina Nonsurgical Orthopedics performs Micronized Adipose (MFAT) cell injections primarily for knee arthritis and bone-on-bone knee pain. We can also use it in the hip and shoulder joints, and sometimes in large tendon tears. 

​​

The procedure involves a minimally-invasive mini liposuction where we concentrate the fat tissue and break it down manually. This process requires years of expertise, and we are highly experienced with optimizing Cell Therapy techniques.

 

NOTE: We do not, and are not allowed to add any enzymes or additives to manipulate the fat tissue beyond what the FDA permits currently. This is called "minimal manipulation", and it is the only way that we can legally offer these injections. 

​

While most patients are familiar with the term "Stem Cell". We have moved to using the term "MFAT" as the FDA does not allow the culturing of tissue in pure stem cells. Any clinic that does so in the United States is at risk of being shut down and prosecuted by the FDA. This also means that we can not quantify absolute numbers of stem cells present in an MFAT sample. ​​
​

WHAT ARE THE BENEFITS?​​

  • High success rates and long-lasting relief (Studies support relief for up to 2-3 years, but we've had patients experience relief for much longer)

  • Well tolerated and less invasive procedure than Bone Marrow Concentrate (BMAC), with less down time

  • Safety profile is very high 

  • Promotes a cellular cushion for joints like the knee, hip, and shoulder  

  • Number of stem cells in adipose tissue is a very high concentration

  • MFAT contains more mesenchymal stem cells (MSCs) than BMAC, and MSCs are a key component of regenerative medicine. MSCs in BMAC decrease significantly after age 50, while stem cells in adipose tissue remain numerous with age.

  • Scientifically-supported treatment option for pain relief

Embryonic Stem Cells
DDDF.jpg
DDDF.jpg

NOT ALL STEM CELLS ARE SAFE OR EFFECTIVE  

Cell therapy ("Stem Cells") has been around for close to a decade in orthopedics, but there are many clinics that promise false results, and use cells that are not allowed by the FDA.  

​

Here are the 3 most important questions to ask when considering Cell Therapy: 

 

WHAT KIND OF CELL IS BEING USED?  

  • Cells that are NOT legal or approved in the US include:  Amniotic / Umbilical Cord Cells, Exosomes, Wharton's Jelly.  

  • Adipose (Fat) & Bone Marrow have the most evidence in orthopedics, and are "permitted" at this time by the FDA, but only if the cells are minimally manipulated (no enzymes or chemicals used to break down or culture the cells).
     

WHAT KIND OF PHYSICIAN IS INJECTING THE CELLS? 

  • Stem Cells and Cell therapy is not risk free. The tissue we inject is very thick and could cause an embolism if injected into a blood vessel.  

  • These type of injections should only be injected under image guidance by an experienced physician. 
     

WHAT KIND OF PROMISES IS THE CLINIC MAKING ABOUT STEM CELLS?

  • Fat and Bone Marrow both have good evidence in advanced arthritis. They both seem to reduce pain, and possibly create a cellular cushion due to the viscosity of the injections. 

  • It is VERY important to note that we do not have large studies confirming that these cells regrow cartilage that is lost, or that we can reverse any disease process. 

  • At Carolina Nonsurgical Orthopedics our goal is to use cell therapy to delay surgery if possible, and to reduce pain. We will never promise that patients will avoid surgery forever.  

​

READ THE LATEST STUDIES ON MFAT CELL THERAPY ("STEM CELLS")>

​

READ MORE ABOUT STEM CELLS 

MFAT Stem Cells for Knee Pain: A Promising Treatment Option Mesenchymal stem cells derived from MFAT (Microfragmented Adipose Tissue) are increasingly being explored as a treatment for knee pain, particularly in individuals suffering from osteoarthritis or cartilage damage. This therapy uses stem cells sourced from a patient’s own fat tissue, offering a regenerative approach to managing knee pain and promoting healing. MFAT is obtained through a minimally invasive process that involves liposuction to extract fat from areas like the abdomen or thighs. The fat is then processed to create microfragmented adipose tissue, which contains not only mesenchymal stem cells but also growth factors, cytokines, and extracellular matrix components that support tissue repair and regeneration. These components help promote the healing of damaged cartilage, reduce inflammation, and stimulate the production of new cells. In knee osteoarthritis, the cartilage in the joint deteriorates over time, leading to pain, swelling, and limited mobility. Traditional treatments such as pain medications, physical therapy, and joint replacement surgery may offer relief, but they often fail to address the underlying tissue damage. MFAT stem cell therapy offers a more regenerative alternative. When injected into the knee joint, MFAT stem cells can reduce inflammation, encourage the growth of new cartilage, and repair damaged tissues. Research into MFAT stem cells for knee treatment has shown promising results. Studies have reported improved pain management, enhanced function, and increased cartilage thickness in patients who undergo this treatment. Unlike other stem cell therapies, MFAT is particularly advantageous because it uses the patient’s own tissue, reducing the risk of immune rejection or complications. While MFAT stem cell therapy is not yet a standard treatment, ongoing studies continue to demonstrate its potential for addressing knee pain and cartilage degeneration in patients with knee osteoarthritis or injury. NOTE: Per the FDA we do not go beyond minimal manipulation of fat tissue. This is illegal in the United States.

WHAT IS MFAT LIPOASPIRATE THERAPY (Stem Cells)?

Carolina Nonsurgical Orthopedics performs Micronized Adipose (MFAT) cell injections primarily for knee arthritis and bone-on-bone knee pain. We also use it in the hip and shoulder joints, and sometimes in large tendon tears.

The short version: we take a small amount of your own fat through a minimally invasive mini-liposuction, concentrate and micro-fragment it the same day, and inject that cell-rich preparation into the arthritic joint or injured tendon under ultrasound guidance. The entire procedure happens in our office in about 60–90 minutes. You walk in and walk out the same day.

The longer version — what's actually in the syringe, why fat, what the FDA allows, and what this can and can't do — is below. We believe you should understand all of it before you spend a dollar.

WHAT'S ACTUALLY IN THE SYRINGE

Fat tissue isn't just filler. Adipose tissue contains a dense population of regenerative cells, including mesenchymal stem cells (MSCs), pericytes, and other stromal vascular cells that participate in tissue repair. When we micro-fragment your fat, we're concentrating that entire living cell population — not isolating one cell type, not growing anything in a lab.

That distinction matters, legally and scientifically:

We do not — and are not allowed to — add enzymes or additives to manipulate the fat beyond what the FDA permits. This is called "minimal manipulation," and it is the only way these injections can legally be offered in the United States. The processing breaks the tissue down mechanically, in a closed sterile system, in the room, on the same day. Nothing is cultured. Nothing is expanded. Nothing is added.

This is why we say "MFAT" instead of "stem cells." While most patients know the term "stem cell," the FDA does not allow the culturing of tissue into pure stem cell products in the United States. Any clinic doing so is at risk of being shut down and prosecuted. It also means we cannot quantify absolute numbers of stem cells in an MFAT sample — any US clinic advertising a specific stem cell count, or offering umbilical, amniotic, or "expanded" stem cells, is operating outside what the FDA permits. We'd rather use the accurate term than the marketing term.

What you're getting is your own tissue, minimally processed, placed precisely where it's needed. That's the whole concept — and its honesty is the point.

WHY FAT INSTEAD OF BONE MARROW?

The other major source of orthobiologic cells is bone marrow concentrate (BMAC), drawn from the pelvis. Both have a role. Here's why we reach for fat first in most cases:

Cell counts hold up with age. This is the big one. The mesenchymal stem cell population in bone marrow drops significantly after age 50 — right when most arthritis patients need treatment most. Adipose tissue stays cell-rich with age. For a 65-year-old with bone-on-bone knees, that difference matters.

The harvest is easier on you. A bone marrow draw goes through bone — it's effective, but it's the more uncomfortable harvest with more downtime. Mini-liposuction through a few-millimeter incision under local anesthesia is generally better tolerated, with most patients describing a few days of deep-bruise soreness at the harvest site.

Higher MSC concentration per volume. Adipose tissue contains a very high concentration of mesenchymal stem cells relative to bone marrow aspirate, and MSCs are a key component of the repair signaling these treatments are designed to deliver.

BMAC still has its place, and we'll tell you when it's the better choice. But for most arthritis patients — especially older ones — MFAT is the stronger starting point.

WHAT CONDITIONS DOES MFAT TREAT?

Knee arthritis is our primary MFAT indication — including bone-on-bone knee pain in patients who want to delay or avoid knee replacement. This is where the deepest evidence sits: the strongest randomized trial data supports meaningful pain and function improvement at 1 year (one prospective study showed benefit waning by 18 months), and in our own practice some patients have done considerably longer. We'd rather be honest about what the trial data actually shows than sell you a settled number.

We also use MFAT for:

  • Hip arthritis — for patients with painful hip osteoarthritis who aren't ready for hip replacement, or who want a longer-acting option than PRP

  • Shoulder arthritis and large rotator cuff tears — selected cases where the joint or tendon needs a bigger biological intervention than PRP alone

  • Large tendon tears and chronic tendinopathy — when PRP hasn't been enough and surgery is the only other conversation

Who is NOT a good candidate: active infection, certain blood disorders, patients in active cancer treatment, severe joint deformity or instability that mechanically requires surgery, or anyone expecting MFAT to regrow lost cartilage or reverse arthritis. It doesn't do those things. We'll tell you directly if your situation calls for a different path — including telling you when surgery is honestly the right answer.

MFAT VS. PRP: HOW TO CHOOSE

Patients ask us this daily, and there's a straightforward framework:

Start with PRP when: the arthritis is mild-to-moderate, this is your first orthobiologic treatment, you want the lowest-cost and lowest-downtime option, or you want to see how your joint responds to a biologic before committing to more.

Consider MFAT when: the arthritis is more advanced, PRP hasn't given enough relief, you want the longest-lasting single intervention available — our own patients routinely report benefit well beyond PRP's typical 6–12 month window, though trial-grade MFAT data tops out at about a year — or you're specifically trying to buy maximum time before a joint replacement.

The practical difference: PRP is a blood draw and an injection — in and out in under an hour. MFAT is a mini-liposuction procedure under local anesthesia: we harvest a small amount of your own fat, process it the same day, and inject the concentrated cell preparation. More involved, a few days of harvest-site soreness, longer-lasting results.

They're complementary, not competing. Many of our patients start with PRP and graduate to MFAT; others go straight to MFAT when the arthritis grade warrants it. We recommend based on your imaging and your goals, not our schedule.

WHAT PROCEDURE DAY LOOKS LIKE

The entire MFAT procedure happens in one visit, typically 60–90 minutes:

  1. Numbing. Local anesthesia at a small harvest site — usually the lower abdomen or flank ("love handle" area). You'll be awake and comfortable the whole time. No general anesthesia, no sedation, no anesthesiologist.

  2. Mini-liposuction. Through a tiny incision (a few millimeters), we gently harvest a small volume of fat using a blunt micro-cannula. This is not cosmetic liposuction — the volumes are small, and the technique is designed to keep the tissue's cell structure intact. This is the step that requires real expertise; we've done it thousands of times.

  3. Processing. Your fat is processed the same day, in the room, using a closed sterile system that micro-fragments the tissue — no enzymes, no additives, no culturing. This is the "minimal manipulation" the FDA requires, and it's the only way these treatments are legally offered in the United States.

  4. Injection. The concentrated MFAT preparation is injected into the target joint or tendon under ultrasound guidance — we watch the needle enter the joint space in real time. For hips, shoulders, and deep structures, guidance isn't optional; it's the difference between treating the joint and missing it.

You walk out the same day. No overnight stay, no surgical incision to heal, no physical therapy protocol measured in months.

RECOVERY AND RESULTS TIMELINE

First few days: Soreness at both the harvest site and the injection site is normal — most patients describe it as a deep-bruise sensation. Over-the-counter pain relief as needed; avoid NSAIDs for the first week if possible, since the early inflammatory phase is part of the healing response these treatments are trying to trigger.

Weeks 1–2: Back to desk work within a day or two; light activity as comfort allows. We advise against high-impact loading while the early healing unfolds. Most patients are surprised at how quickly they're back to normal routines.

Weeks 4–12: This is when improvement typically builds — gradually, not overnight. Stiffness tends to ease first for most patients, then pain with activity. This is biology, not a drug effect; it takes weeks, not hours.

Months 3–6: Full assessment of response. In published studies the benefit is best established at 1 year (waning by 18 months in one prospective study); in our clinical experience the plateau often holds considerably longer — we've had patients report relief for multiple years. Arthritis is still arthritis, though. This isn't permanent, and anyone promising permanent is selling something.

What we monitor: we'll see you for follow-up and track your pain and function scores. If you're not responding as expected, we reassess rather than assume — and we discuss next steps honestly, whether that's a different orthobiologic approach or a surgical referral.

WHAT ARE THE BENEFITS?

  • High success rates and long-lasting relief. The strongest trial data supports meaningful relief at one year; our clinical experience includes patients doing well well beyond that. Among non-surgical options for advanced arthritis, MFAT is the longest-acting single intervention we offer.

  • Less invasive than the alternatives. Well tolerated, office-based, no general anesthesia — and a gentler harvest with less downtime than bone marrow concentrate (BMAC).

  • Very high safety profile. It's your own tissue, processed the same day in a closed sterile system. Serious complications are rare (see below).

  • A cellular cushion for the joint. The micro-fragmented adipose tissue provides both a physical cushioning scaffold and a concentrated population of repair-signaling cells in knees, hips, and shoulders alike.

  • Age-resilient cell source. Adipose MSC counts stay high with age, while bone marrow MSCs fall off after 50 — making MFAT particularly well suited to the older arthritis population.

SAFETY AND RISKS — THE HONEST VERSION

The safety profile is very high, and the "your own tissue, same day" design is a big reason why — there's no rejection risk, no disease transmission risk, no foreign material. But "very safe" isn't "risk-free," and you should hear the real list:

  • Harvest-site soreness, bruising, and swelling — expected, resolves in days to a couple of weeks

  • Injection-site soreness and temporary stiffness — expected, typically a few days

  • Infection — rare with sterile technique, but any injection carries this risk; we use full sterile prep and ultrasound guidance

  • Bleeding or hematoma at the harvest site — uncommon, usually minor

  • No improvement — the most common "complication." Not every joint responds, and we'd rather you know that before treatment than after

We track our outcomes. If a treatment isn't working, we say so.

WHAT MFAT CAN'T DO

Let's be as clear about the limits as the benefits:

  • It doesn't regrow lost cartilage. No orthobiologic currently offered in the United States does, whatever you've read online. Anyone promising cartilage regrowth is not describing MFAT — they're describing something the FDA doesn't allow.

  • It doesn't reverse arthritis. The arthritis is still there. The goal is less pain, better function, and more time before (or instead of) joint replacement.

  • It doesn't fix mechanical problems. A knee that's severely bowed, a hip that's structurally collapsed, a tendon that's fully retracted — those are mechanical failures, and biology doesn't re-engineer mechanics.

  • It isn't instant. If you need to be pain-free by next weekend for a trip, this isn't the treatment.

We put this here because the clinics that hide the limits are the reason patients don't trust the field. We'd rather earn the trust.

COST AND TRANSPARENCY

MFAT is a cash-pay procedure — insurance doesn't cover orthobiologic treatments. Our fee is [PRICE] for the complete procedure: consultation and imaging review, the harvest, same-day processing, and the ultrasound-guided injection.

That fee covers everything — no facility fees, no anesthesia bills, no surprise add-ons weeks later. For comparison, a single knee replacement typically bills $30,000–$50,000+ before insurance, with weeks of recovery and months of rehab.

We also offer PRP at a lower price point for milder disease — and we'll never steer you to MFAT when PRP would do. The recommendation follows the joint, not the price tag.

FREQUENTLY ASKED QUESTIONS

Is MFAT the same as "stem cell therapy"?
MFAT contains mesenchymal stem cells (MSCs) along with the full complement of fat-derived regenerative cells — but it's not a purified, counted stem cell product, and the FDA doesn't allow anyone in the US to culture or expand cells. We use the term MFAT precisely because it's accurate. Any US clinic advertising counted, cultured, umbilical, or amniotic "stem cells" is operating outside what the FDA permits.

Why not just do bone marrow (BMAC)?
BMAC is a legitimate option, and there are cases where we recommend it. But for most arthritis patients — especially over 50 — fat wins on three counts: cell counts don't fall off with age the way marrow does, the harvest is better tolerated, and the MSC concentration per volume is higher.

Does it hurt?
The harvest site feels like a deep bruise for several days; the injection itself is done under local anesthesia with ultrasound guidance. Most patients are surprised at how manageable it is — this is an office procedure, not surgery.

How long does it last?
Trial-grade studies support about a year of meaningful relief; in our clinical experience patients often get considerably longer. It's not permanent — arthritis is still arthritis — but for many patients it's years of delayed or avoided surgery.

Am I too old — or too young?
One genuine advantage of fat-derived cells: unlike bone marrow, whose stem cell counts drop sharply after age 50, adipose tissue remains cell-rich with age. Older patients are often excellent MFAT candidates. Younger patients with early arthritis may do just as well with PRP at lower cost — we'll say so.

What if it doesn't work?
Then we've learned something valuable about your joint, and we discuss next steps honestly — which may include a different orthobiologic approach or a surgical referral. We track outcomes; we don't disappear after the injection.

Can I do both knees / multiple joints?
Yes — commonly done in the same visit when both joints qualify, since the harvest is already complete. Ask us about combined treatment; it's more efficient than two separate procedures.

Blue Modern Medical Center Flyer (2)_edited.jpg
Logo_graphiconly_edited.png

WHY CAROLINA
NONSURGICAL ORTHOPEDICS

  • All Providers are BOARD CERTIFIED and Specially Trained in Nonsurgical Orthopedics 

  • Over 50,000+ and Counting Procedures Performed

  • Procedures Performed with Ultrasound Guidance for Accuracy and Safety 

  • Local and Independent Practice That is NOT a Franchise 

  • Discounts for Service Members, Teachers, and Public Servants 

  • Serving Raleigh Since 2013

REQUEST AN APPOINTMENT

bottom of page